Why is Aarti Pharma falling/rising?

As of 15-Sep, Aarti Pharmalabs Ltd is experiencing a price increase, currently at Rs 937.60, reflecting a rise of Rs 11.05 or 1.19%. The stock has shown strong performance, gaining 4.06% over the last three days and outperforming its sector by 1.64% today. It is also close to its 52-week high, just 3.62% away from Rs 971.5. Over the past week, the stock has risen by 6.42%, and it has generated a remarkable 41.40% return over the past year, significantly outperforming the broader market, which has seen negative returns. The company's strong financial metrics, including a low Debt to EBITDA ratio of 0.63 and a return on capital employed (ROCE) of 16.1, contribute to its attractive valuation and support the recent upward movement.
In the broader market context, Aarti Pharmalabs has outperformed the benchmark Sensex, which has only increased by 1.24% over the past week and 1.47% over the past month. Despite a decline in investor participation, as indicated by a 12.59% drop in delivery volume, the stock remains liquid enough for trading. The company's ability to generate significant returns, coupled with its strong fundamentals, positions it favorably against the backdrop of a market that has struggled, as evidenced by the BSE500's negative return of -3.45% over the past year. This combination of strong stock performance and favorable financial indicators is driving the stock's rise.